跳至主要内容
临床试验/NCT05544734
NCT05544734已完成4 期

Analysis of Hydrocodone Compared to Acetaminophen and Ibuprofen for Post-nail Procedure Analgesia

Weill Medical College of Cornell University1 个研究点 分布在 1 个国家目标入组 20 人开始时间: 2022年11月10日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
4 期
状态
已完成
入组人数
20
试验地点
1
主要终点
Change From Baseline in Pain Scores on Postoperative Day 2, as Measured by the Wong-Baker 0-to-10 Pain Scale

研究概览

简要总结

The purpose of this study is to assess the safety and efficacy of ropivacaine and hydrocodone for nail-procedure associated pain management. The investigators hypothesize that ropivacaine with hydrocodone will be superior to ropivacaine with acetaminophen and ibuprofen for managing pain.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 95 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Patients undergoing fingernail or toenail, excision, or shave biopsy
  • Must understand and voluntarily sign an informed consent form
  • Must be male or female and aged 18-95 years at time of consent
  • Must be able to adhere to the study visit schedule and other protocol requirements

排除标准

  • Subject is unable to provide written informed consent for any reason
  • Subject has peripheral vascular disease, arterial insufficiency, peripheral neuropathy
  • Subject is on Aspirin, NSAIDs, or consumes a chronic medication for control of any other chronic pain
  • Subject has a history of opioid or alcohol use disorder
  • Subject has a history of peptic ulcer disease, gastritis, chronic renal insufficiency or a history of kidney disease, or has underlying liver disease
  • Subject has a history of severe constipation
  • Subject is sensitive or allergic to any of the elements included in this study
  • Subject is unable to complete the required pain dairy
  • Subject is pregnant, planning pregnancy, or nursing

研究组 & 干预措施

Hydrocodone 5mg/acetaminophen 325mg

Active Comparator

Participants receive oral hydrocodone 5 mg/acetaminophen 325 mg every 4 hours for 2 days, followed by oral acetaminophen 1000 mg and oral ibuprofen 400 mg every 6 hours for 4 days

干预措施: Hydrocodone 5Mg/Acetaminophen 325Mg Tab (Drug)

Hydrocodone 5mg/acetaminophen 325mg

Active Comparator

Participants receive oral hydrocodone 5 mg/acetaminophen 325 mg every 4 hours for 2 days, followed by oral acetaminophen 1000 mg and oral ibuprofen 400 mg every 6 hours for 4 days

干预措施: Acetaminophen 1000mg (Drug)

Hydrocodone 5mg/acetaminophen 325mg

Active Comparator

Participants receive oral hydrocodone 5 mg/acetaminophen 325 mg every 4 hours for 2 days, followed by oral acetaminophen 1000 mg and oral ibuprofen 400 mg every 6 hours for 4 days

干预措施: Ibuprofen 400 mg (Drug)

Acetaminophen 1000mg + Ibuprofen 400mg

Active Comparator

Participants receive oral acetaminophen 1000 mg and oral ibuprofen 400 mg every 6 hours for 6 days

干预措施: Acetaminophen 1000mg (Drug)

Acetaminophen 1000mg + Ibuprofen 400mg

Active Comparator

Participants receive oral acetaminophen 1000 mg and oral ibuprofen 400 mg every 6 hours for 6 days

干预措施: Ibuprofen 400 mg (Drug)

结局指标

主要结局

Change From Baseline in Pain Scores on Postoperative Day 2, as Measured by the Wong-Baker 0-to-10 Pain Scale

时间窗: Baseline, 2 days

Change in pain scores obtained with the Wong-Baker 0-to-10 pain scale between the 2 groups on postoperative day 2. The Wong-Baker 0-to-10 pain scale is used for rating the severity of pain, with scores ranging from 0 to 10, and higher scores indicating greater severity of pain.

次要结局

  • Change in Health-related Quality of Life Scores on Postoperative Days 3 and 6, as Measured by an Adapted APS-POQ-R Questionnaire(3 days, 6 days (end of study))

研究者

申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验